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he cellular decoding of receptor-induced signaling is
based in part on the spatiotemporal activation pattern
of PKC isoforms. Because classical and novel PKC
isoforms contain diacylglycerol (DAG)-binding C1 domains,
they may compete for DAG binding. We reasoned that a
 
Ca
 
2
 
 
 
-induced membrane association of classical PKCs
may accelerate the DAG binding and thereby prevent trans-
location of novel PKCs. Simultaneous imaging of ﬂuorescent
PKC fusion proteins revealed that during receptor stimulation,
 
PKC
 
 
 
 accumulated in the plasma membrane with a diffusion-
limited kinetic, whereas translocation of PKC
 
 
 
 was delayed
and attenuated. In BAPTA-loaded cells, however, a selective
 
translocation of PKC
 
 
 
, but not of coexpressed PKC
 
 
 
, was
T
 
evident. A membrane-permeable DAG analogue displayed
 
a higher binding afﬁnity for PKC
 
 
 
 than for PKC
 
 
 
. Subsequent
photolysis of caged Ca
 
2
 
 
 
 immediately recruited PKC
 
 
 
 to
the membrane, and DAG-bound PKC
 
 
 
 was displaced. At low
expression levels of PKC
 
 
 
, PKC
 
 
 
 concentration dependently
prevented the PKC
 
 
 
 translocation with half-maximal effects at
equimolar coexpression. Furthermore, translocation of endo-
genous PKCs in vascular smooth muscle cells corroborated
the model that a competition between PKC isoforms for
DAG binding occurs at native expression levels. We conclude
 
that Ca
 
2
 
 
 
-controlled competitive DAG binding contributes
to the selective recruitment of PKC isoforms after receptor
activation.
 
Introduction
 
PKC isoenzymes form a family of serine/threonine kinases that
 
are grouped into classical (PKC
 
 
 
, 
 
 
 
1, 
 
 
 
2, and 
 
 
 
), novel
(PKC
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
), and atypical (PKC
 
  
 
and 
 
 
 
/
 
 
 
) isoenzymes
based on their structural similarities and cofactor require-
ments (Nishizuka, 1992; Mellor and Parker, 1998; Ron and
Kazanietz, 1999). In contrast to their highly conserved
COOH-terminal catalytic core domains, NH
 
2
 
-terminal
regulatory domains are more variable. The diacylglycerol
(DAG)*-mediated activation of classical and novel PKC iso-
forms is accomplished by a C1 domain that contains two
cysteine-rich regions as DAG-docking motifs. DAG binding
fulfills a dual role by recruiting classical and novel PKCs to
the membrane compartment and by weakening the interaction
of an inhibitory pseudosubstrate domain with the COOH-
terminal catalytic core (Oancea and Meyer, 1998). The
mode of activation, therefore, relies on the DAG-induced
release from an intramolecular block. In contrast to novel
PKC isoforms, classical PKCs are additionally regulated by
 
the cytosolic Ca
 
2
 
 
 
 concentration ([Ca
 
2
 
 
 
]
 
i
 
). Their C2 domains,
in conjunction with the anionic phospholipid phosphati-
dylserine, bind two or three calcium ions (Shao et al., 1996;
Sutton and Sprang, 1998; Verdaguer et al., 1999). The
bound Ca
 
2
 
 
 
 electrostatically facilitates the plasma membrane
docking of classical PKC isoforms and may, thus, explain the
diffusion-limited translocation kinetics and high collisional
coupling efficiency of classical PKC isoforms observed either
in vitro or in living cells (Nalefski and Newton, 2001;
Schaefer et al., 2001).
In virtually each cell type and tissue, at least one member
of the classical and one of the novel PKC isoforms are co-
expressed (Wetsel et al., 1992; Dekker and Parker, 1994; Liu
and Heckman, 1998). Stimulation of PLC-coupled receptors
results in DAG formation and, via inositol-1,4,5-trisphosphate
 
(InsP
 
3
 
) receptor activation, increases the [Ca
 
2
 
 
 
]
 
i
 
. One might
expect that classical and novel PKC isotypes are recruited to
the plasma membrane in parallel. Nonetheless, upon receptor
stimulation, an isotype-selective translocation of PKCs has
been observed in several cell systems (Dekker and Parker,
1994). This isotype-specific membrane translocation of
PKC isoenzymes must be based on mechanisms that take effect
downstream of receptor activation. Although a number of
PKC-interacting proteins sequester activated PKCs to various
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compartments (Jaken and Parker, 2000), little is known
about the mechanisms that control the selectivity of the ini-
tial membrane recruitment of distinct PKC isoforms, which
is most likely based on a protein–lipid interaction.
We have recently shown that a Ca
 
2
 
 
 
-induced plasma
membrane translocation of classical PKCs is a diffusion-
driven and diffusion-limited binding process that is charac-
terized by a high collisional coupling efficiency (Schaefer et
al., 2001). Because both classical and novel PKCs share a
DAG-binding C1 domain, the highly efficient Ca
 
2
 
 
 
-driven
plasma membrane association of classical PKCs suggests
that, by finally competing for the same acceptor, classical
PKCs may prevent translocation of coexpressed novel PKCs.
To observe the interplay of PKC translocations in living
cells, we generated cyan and yellow fluorescent PKC fusion
proteins and applied a multivariate regression algorithm that
reliably dissects signals arising from multiple, spectrally over-
lapping fluorochromes. We provide evidence that an ago-
nist-induced selective membrane recruitment of classical
and/or novel PKC isoenzymes can result from a Ca
 
2
 
 
 
-con-
trolled competitive binding to limiting plasma membrane
concentrations of DAGs.
 
Results
 
Excitation and emission spectra of fluorochromes form fin-
gerprints that can be used to discriminate a number of dyes.
Taking advantage of fast monochromators and linearly scal-
ing CCD cameras, we set up a spectral evaluation method
that estimates the contribution of single fluorochromes to
complex signals in dynamic, multicolor labeling experi-
ments. Image bursts were taken at five to eight different exci-
tation wavelengths to record the spectral characteristics of
the probe. These data were then compared with spectrally re-
solved datasets of each isolate fluorochrome (Fig. 1 A). Be-
cause fluorescence signals of a probe are additively composed
of spectra of single fluorochromes, their relative contribution
to the composite signal could be estimated with a pixel-by-
pixel multivariate, linear regression analysis (results for two
regions of interest are depicted in Fig. 1, B and C). Spectral
shifts of 
 
 
 
15 nm were sufficient to achieve a reliable separa-
tion of fluorochromes such as the red-shifted green (GFP-
S65T) and yellow (YFP) fluorescent proteins (unpublished
data). Furthermore, by dissecting signals that arise from the
spectrally shifting free and Ca
 
2
 
 
 
-bound forms of fura-2, a
rapid calibration of cytosolic Ca
 
2
 
 
 
 concentrations could also
be achieved. Using this regression-based spectral evaluation
method, we synchronously coimaged receptor-induced [Ca
 
2
 
 
 
]
 
i
 
transients and the translocation of CFP and YFP fusion pro-
teins of classical and novel PKC isotypes.
Our recent finding that the receptor-induced transloca-
tion of classical PKC isoenzymes is a Ca
 
2
 
 
 
-driven diffusion-
limited binding process (Schaefer et al., 2001) prompted us
to hypothesize that after initially attaching to the plasma
membrane via interaction of the Ca
 
2
 
 
 
-binding C2 domain
and phosphatidylserine, the subsequent search for DAGs
may be restricted to a two-dimensional space. This two-step
procedure of classical PKCs to scan for DAGs in the plasma
membrane may be more efficient than the translocation
mechanism of novel PKCs that have to undergo several col-
lisions with the plasma membrane until they eventually hit a
DAG molecule. Indeed, in transiently transfected human
embryonic kidney (HEK) cells, YFP-tagged PKC
 
 
 
 translo-
cated to the plasma membrane in response to maximal stim-
ulation of a cotransfected histamine H
 
1
 
 receptor, whereas
coexpressed CFP-fused PKC
 
 
 
 remained mostly cytosolic
(Fig. 2, A and C). This effect was not due to massive dis-
crepancies in the expression levels of the coexpressed PKC
isoforms because the molar ratio between PKC
 
 
 
–YFP and
PKC
 
 
 
–CFP was 
 
 
 
1:1.5, as detected by fluorescence intensi-
ties of the respective tags and a calibration procedure with an
Figure 1. Spectral deconvolution of overlapping fluorochromes 
eliminates cross-bleeding between multiple fluorochromes. 
(A) Excitation spectra of single fluorochromes were recorded by digital 
fluorescence microscopy. Spectra of Ca
2 -bound fura-2 and free fura-2 
were obtained in HEK cells after equilibration with ionomycin (10  M 
for 3 h) in the presence (Ca
2 –fura-2) and absence (free fura-2) of 
external Ca
2 , respectively. Excitation spectra of CFP and YFP were 
acquired after transient expression of the respective fluorescent protein 
in HEK cells. All spectra were normalized to the maximal fluorescence 
intensities of the respective dye. (B and C) Due to differential 
distribution of fluorescent molecules in different regions of interest 
(ROI) corresponding to the peripheral cytosol (B) or the nucleus (C), 
cross-bleeding of fluorochromes frequently accounts for a major 
portion of the signals at a given excitation wavelength. The spectrum 
over the respective area (Fcytosol or Fnucleus) is additively composed of 
signals arising from single fluorochromes (FCa2 –fura-2, Ffree fura-2, FCFP, and 
FYFP). The relative contribution of each fluorochrome to the composite 
spectrum of the probe was calculated by a regression-based spectral 
evaluation algorithm. 
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intramolecularly fused CFP–YFP tandem protein (see Mate-
rials and methods). Simultaneous imaging of two classical
PKC isoforms, PKC
 
 
 
–YFP and PKC
 
 
 
1–CFP (molar ratio
1:2), however, showed coincident [Ca
 
2
 
 
 
]
 
i
 
 signals and simul-
taneous plasma membrane translocation of both PKCs (Fig.
2, B and C). Switching the fluorescent tags (PKC
 
 
 
–CFP co-
expressed with PKC
 
 
 
–YFP) did not alter the impaired trans-
location of the novel isotype in coexpression experiments.
Immunoblot analysis of endogenously expressed PKC
 
 
 
 and
PKC
 
 
 
 along with a dilution series of transiently transfected
fluorescent fusion proteins demonstrates an 
 
 
 
10-fold over-
expression of PKC
 
 
 
 and an 
 
 
 
100-fold overexpression of
PKC
 
 
 
, as compared with endogenous expression levels (Fig.
2 D). Thus, the endogenously expressed PKC isoforms are
unlikely to affect the translocation of transiently overex-
pressed fluorescent PKC fusion proteins. Fluorescent PKC
 
 
 
fusion proteins translocated in response to histamine recep-
tor stimulation when expressed alone (Fig. 3) or when coex-
pressed with the unfused CFP (unpublished data), indicat-
Figure 2. PKC  suppresses a receptor-induced plasma membrane 
translocation of PKC . (A) Transiently transfected HEK cells were 
stimulated via a coexpressed H1 histamine receptor (histamine 
100  M), and fluorescences were recorded at multiple excitation 
wavelengths (340, 360, 380, 410, 430, 450, and 480 nm) at the 
indicated time points after agonist application. Image data were 
processed by a pixel-by-pixel regression-based spectral evaluation 
algorithm to dissect signals arising from CFP and YFP and to 
calibrate [Ca
2 ]i. The calibrated [Ca
2 ]i is encoded by a rainbow 
pseudocolor scale (0–1,000 nM). Note the poor translocation of 
PKC  and the coincident [Ca
2 ]i elevation and translocation of PKC . 
(B) Simultaneous imaging of the histamine-induced translocation 
of PKC –YFP and PKC 1–CFP. Bars, 20  m. (C) Time-course of 
translocation of PKC fusion proteins from the experiments shown in 
A and B. For explanation of the assay, see Fig. 3 legend. (D) Expression 
levels of transiently overexpressed PKC –YFP and PKC –YFP were 
compared with those of endogenously expressed PKC isoenzymes 
by immunoblot analysis. Cytosolic fractions were prepared from 
transiently transfected cells (transfection efficiency  50%) or from 
wild-type HEK cells (WT). The undiluted samples were adjusted to 
contain 20  g of total protein per lane. Blots were probed with 
either anti-PKC  or anti-PKC  antibodies; the molecular weight of 
the bands correspond to the expected sizes of wild-type PKCs or the 
respective YFP-fused proteins.
Figure 3. Ca
2 -dependent collisional coupling efficiency of PKC  
and PKC . Transiently transfected HEK cells were loaded with 
fura-2 and imaged by digital videomicroscopy. (A) The fluorometric 
determination of PKC translocation was based on the measurement 
of mean fluorescence intensities over ROIs that were defined over 
the outer border of the cell mostly representing the plasma membrane 
(ROImemb) and over the cytosol (ROIcyt) of the same cell. Bar, 5  m. 
(B and C, top and middle) The receptor-induced plasma membrane 
translocation of PKC –YFP (B) or PKC –YFP (C) was monitored in 
HEK cells with (gray lines) or without (black lines) preincubation with 
BAPTA-AM (10  M, 15 min at 37 C). HEK cells were cotransfected 
with plasmids encoding the indicated PKC fusion proteins and the 
H1 histamine receptor. The addition of histamine (100  M) to the 
bath solution is indicated by arrows. The mean fluorescence intensities 
(Fmemb and Fcyt) were calculated for the ROImemb and ROIcyt of single 
cells, expressed as ratios, and normalized to the initial values. 
(B and C, bottom) [Ca
2 ]i signals were recorded in parallel to 
control the efficiency of the Ca
2  clamp by intracellularly loaded 
BAPTA. Data represent means and SEM of n   3–4 independent 
experiments (each experiment comprises averaged data of 6–15 
single cells).294 The Journal of Cell Biology | Volume 159, Number 2, 2002
ing that coexpressed PKC  caused the attenuation of PKC 
translocation.
The initial step for the translocation of classical PKCs
most likely relies on an interaction of the Ca
2 -binding C2
domain with phosphatidylserine. Therefore, chelation of in-
tracellular Ca
2  may affect both the efficiency and the tem-
poral pattern of PKC  translocation. To evaluate the effect
of intracellularly loaded BAPTA on the kinetics of PKC
translocation, the localization of fluorescent PKC fusion
proteins was assessed by digital videomicroscopy and subse-
quent analysis of fluorescence intensities within regions of
interest defined over the plasma membrane and the cytosol
of single cells, as shown in Fig. 3 A. The results demonstrate
that the histamine-induced plasma membrane docking of
PKC –YFP is markedly affected by BAPTA-AM pretreat-
ment. The plasma membrane association of PKC  was de-
layed, and the efficiency of the binding was reduced under
conditions where the formation of DAGs is the only driving
force for the PKC  translocation (Fig. 3 B). The half-maxi-
mal translocation of PKC  in the absence and presence of
the Ca
2  chelator were observed 1.2 s and 7.5 s after hista-
mine application, respectively. The agonist-induced redistri-
bution of the DAG-sensing PKC –YFP remained mostly
unchanged irrespective of the presence or absence of [Ca
2 ]i
transients (Fig. 3 C). Half-maximal translocation of PKC –
YFP was observed 6–7 s after histamine stimulation in un-
treated or in BAPTA-loaded cells. Upon buffering of [Ca
2 ]i
signals, a slight, but statistically not significant, increase in
the translocation efficiencies of PKC –YFP could be ob-
served (Fig. 3 C, top and middle). Because the endogenous
expression level of PKC  in HEK293 cells is not neglectably
low (Fig. 2 D), it is possible that this paradoxical inverse
Ca
2  sensitivity of PKC  translocation could reflect a com-
petition with endogenous classical PKCs. Applying the spec-
tral evaluation method, [Ca
2 ]i could be detected in parallel
to control the Ca
2  clamp of intracellularly loaded BAPTA
in the same cells that were used to detect the PKC transloca-
tion (Fig. 3, B and C, bottom). Thus, in the absence of
[Ca
2 ]i signals, the receptor-induced PKC  translocation no
longer precedes the membrane recruitment of PKC . Fur-
thermore, the weak and delayed translocation of PKC –
YFP in BAPTA-loaded cells indicates that PKC  may bind
to DAGs with a lower affinity than the novel PKC isoform.
A possible Ca
2 -controlled competition for the membrane
anchorage of classical and novel PKCs was tested by coex-
pressing CFP- and YFP-tagged PKC fusion proteins and al-
tering the intracellular Ca
2  concentrations. In HEK cells
coexpressing PKC –CFP and PKC –YFP, maximal stimu-
lation of a coexpressed histamine receptor induced a similar
translocation of PKC  (Fig. 4 A) as in cells that expressed
PKC  alone (Fig. 3 B). The histamine-induced transloca-
tion of PKC , however, was markedly delayed, and the
maximal membrane attachment was reduced in cells that
coexpressed PKC  as compared with cells that were not
cotransfected with PKC  (Fig. 3 C; Fig. 4 A). In PKC /
PKC -coexpressing cells, a pretreatment with BAPTA-AM
reversed the selectivity of the receptor-induced PKC translo-
cation. The histamine-induced translocation of PKC  was
further suppressed, whereas the membrane association of co-
expressed PKC  now remained as efficient as in cells that
only expressed the PKC  fusion protein (Fig. 4 B as com-
pared with Fig. 3, B and C). In another experiment, we co-
expressed the H1 receptor together with PKC –CFP and
only trace amounts of PKC –YFP (molar ratio between
PKC –CFP and PKC –YFP   5:1). Under these condi-
tions, the histamine-induced translocation of PKC –CFP
displayed identical efficiencies and kinetics as shown for
PKC –YFP without cotransfected PKC  (Fig. 3 C).
The competitive effect was not restricted to stimulation
via the coexpressed H1 histamine receptor. When PKC –
CFP/PKC –YFP-coexpressing HEK cells were stimulated
via a coexpressed human EGF receptor (EGF, 50 ng/ml),
PKC  was efficiently translocated whereas PKC  remained
mostly cytosolic, and BAPTA loading again reversed the
selectivity of PKC translocation (unpublished data). In
PKC /PKC -coexpressing cells that were stimulated with
submaximal effective concentrations of carbachol (20  M)
Figure 4. A competitive translocation of PKC isoforms is controlled 
by [Ca
2 ]i. The Ca
2  dependency of the histamine- or carbachol-
induced PKC translocation was analyzed in HEK cells that were 
transiently transfected with PKC –CFP, PKC –YFP, and the H1 
histamine receptor. Cells were stimulated with either histamine 
(100  M; A and B) or carbachol (20  M; C and D) acting on an 
endogenously expressed M1 family acetylcholine receptor. The 
agonist application is indicated by arrows. [Ca
2 ]i elevations and 
translocations of the indicated PKC isoenzymes were simultaneously 
recorded without (A and C) or with pretreatment with 10  M 
BAPTA-AM (B and D). The translocation of fluorescent PKC fusion 
proteins was assessed as described in Fig. 3. Data represent means 
and SEM of n   3–5 independent experiments. In each experiment, 
data of 8–22 single cells were averaged.Competitive DAG binding of protein kinases C | Lenz et al. 295
via an endogenously expressed M1 family muscarinic recep-
tor, a smaller and more short-lived [Ca
2 ]i signal indicates a
weaker input into the PLC signaling pathway as compared
with the full stimulation of a coexpressed H1 histamine
receptor (Fig. 4, A and C). Under these conditions, the
translocation of PKC –CFP was still evident, whereas trans-
location of PKC –YFP was poorly detectable. When carba-
chol-induced [Ca
2 ]i transients were buffered by intracellular
BAPTA, PKC –YFP was translocated to the plasma mem-
brane although the stimulation via the endogenous receptor
resulted in a more delayed and weaker translocation as com-
pared with the stimulation of the exogenously transfected
H1 receptor (Fig. 4, B and D). In the presence of [Ca
2 ]i sig-
nals, the highly efficient membrane association of classical
PKC isoforms may occupy the accessible DAG molecules
and thereby displace novel PKC isoforms. In BAPTA-loaded
cells, however, the remaining driving force for the hista-
mine-, carbachol-, or EGF-induced PKC translocation of
classical or novel PKCs is given by the formation of endoge-
nous DAG species by PLC-  or -  isoforms. Because PKC 
selectively translocates to the plasma membrane under these
conditions, we conclude that the novel PKC isoenzyme
binds to endogenous DAG species with a higher affinity
than the coexpressed PKC .
This concept is corroborated by the finding that low con-
centrations (20–100  M) of the membrane-permeable di-
octanoyl-s,n-glycerol (DOG) selectively recruited PKC  to the
plasma membrane, whereas PKC  required  10-fold higher
DOG concentrations for a comparable plasma membrane
association (Fig. 5). The concentration-dependent plasma
membrane association was assessed by confocal measurement
of transcellular concentration profiles of PKC isoforms 60 s
after the addition of DOG (Fig. 5 A). The EC50 for the
DOG-induced membrane association of PKC –YFP was
 90   M, and saturation was observed at concentrations
 300  M. The fluorescent PKC  fusion protein accumu-
lated in the plasma membrane only at DOG concentrations
 200  M (Fig. 5 B). Thus, in living cells, the affinity of
PKC  to bind either a membrane-permeable DAG analogue
or the endogenous DAG species formed by PLC-  or -  is
indeed higher than that of the classical PKC .
Figure 5. Differential DAG binding affinity of PKC  and PKC  in 
living cells. Fluorescent PKC fusion proteins were transiently 
transfected in HEK cells and challenged with various concentrations 
of the membrane-permeable DOG. (A) Confocal images of a 
PKC –YFP-expressing cell were taken before and 60 s after application 
of DOG (300  M), and fluorescence intensity profiles were recorded 
over the cytoplasm and the adjacent plasma membrane of single 
cells. (B) The mean cytosolic and plasma membrane fluorescence 
intensities were recorded for either PKC  (open symbols) or PKC  
(filled symbols), as shown in A, and expressed as ratios. Data 
represent means   SEM of five independent experiments (each 
experiment comprises averaged data of three to five cells).
Figure 6. PKC  and PKC  compete for DAG binding in a Ca
2 -
dependent manner. (A) HEK cells were transiently cotransfected 
with PKC –CFP (shown in blue) and PKC –YFP (yellow channel), 
loaded with caged Ca
2  (o-nitrophenyl-EGTA, 10  M), and imaged 
by confocal time-lapse microscopy. Images before (1) and 3 min 
after (2) the addition of the membrane-permeable DOG (10  M) 
are shown. Subsequently, caged Ca
2  was photolyzed by applying 
a brief pulse of maximal laser energy at 364 nm (3). Bar, 10  m. 
(B) Kinetic analysis of the whole experiment shown in A. Fluorescence 
intensities over the plasma membrane and the cytosol are expressed 
as ratios and SD of four cells. Comparable cell groups were allocated 
on the same coverslip and subjected to photolysis of caged Ca
2  
(as indicated by the flash symbols) at later time points. (C) Similar 
experiment as in B, but with separately transfected PKC –CFP and 
PKC –YFP so that each cell expresses either PKC –YFP or PKC –CFP. 
(D) Equivalent experiment as in C, but without previous addition 
of DOG. Representatives of three independent experiments with 
similar results are shown.296 The Journal of Cell Biology | Volume 159, Number 2, 2002
When PKC –YFP/PKC –CFP-coexpressing cells were
incubated with 20  M DOG for  1 min, PKC  slowly ac-
cumulated in the plasma membrane, indicating that the
number of accessible DOG molecules was just sufficient to
anchor the available PKC –YFP molecules. The subsequent
photolysis of caged Ca
2  (intracellularly loaded o-nitrophe-
nyl-EGTA) resulted in an immediate membrane transloca-
tion of PKC . Coincident with the accumulation of the
classical PKC in the plasma membrane, the DOG-bound
PKC –YFP was displaced by  50% (Fig. 6, A and B). The
observed displacement of PKC  became less efficient after
extended coincubation with DOG, although PKC –CFP
was efficiently translocated in response to Ca
2  pulses (Fig.
6 B, middle and right). Similarly, a displacement of PKC 
by Ca
2 -driven membrane association of PKC  did not oc-
cur when high DOG concentrations (100–200  M) were
applied (unpublished data). We conclude that the Ca
2 -
driven displacement of DAG-bound PKC  is restricted to
situations in which the number of accessible DAG molecules
in the inner leaflet of the plasma membrane is not in vast ex-
cess over the number of PKC molecules that compete for the
DAG binding. Because a pretreatment with bisindolylmale-
imide I (1  M for 15 min) did not prevent the displacement
of DOG-bound PKC  by coexpressed PKC  (unpublished
data), the competitive effect does not rely on the catalytic ac-
tivity of coexpressed PKC isoforms.
To monitor the localization of individually expressed PKC
isoforms during photolysis of caged Ca
2 , PKC –CFP and
PKC –YFP were separately transfected into different cell
populations and were then mixed and seeded on one cover-
slip. In cells that expressed only PKC –CFP, the novel iso-
form again slowly translocated upon addition of DOG (20
 M), but a photolysis of Ca
2  failed to displace the DOG-
bound PKC  (Fig. 6 C). The Ca
2  pulse, however, was suffi-
cient because a robust translocation could be observed in
PKC –YFP-expressing cells located within the same visual
field (Fig. 6 C). Thus, the competitive effect depends on a
Ca
2 -driven membrane translocation of PKC  within the
same cell. In the absence of exogenous DOG, the Ca
2  pulse
selectively induced a translocation of PKC –CFP and did
not affect the localization of PKC –YFP (Fig. 6 D).
Up to this point, the competition for DAG binding was
observed at high PKC expression levels. This competitive
mechanism may also operate at more physiological condi-
tions with lower PKC expression levels and weaker PLC
stimulation. We therefore generated a stably transfected
HEKPKC –YFP cell line that typically expresses  10-fold lower
amounts of PKC –YFP per cell than transiently transfected
cells. Cells were stimulated with carbachol (100  M) acting
on an endogenously expressed M1 family muscarinic acetyl-
choline receptor. This treatment caused a markedly weaker
plasma membrane association of PKC –YFP as compared
with maximal stimulation via a cotransfected H1 receptor
(Fig. 7 A). Another estimate to quantify the phosphatidyl-
4,5-bisphosphate (PIP2) breakdown by stimulation of the
endogenously expressed M1 receptor was based on the mem-
brane dissociation of a PIP2- and InsP3-binding YFP-fused
PLC 1 PH domain. The results confirm a remaining 20%
PIP2 hydrolysis as compared with stimulation of the tran-
siently coexpressed H1 receptor (unpublished data). As ex-
pected from the positive local feedback of InsP3 and Ca
2  at
InsP3 receptors, the reduced input into the PLC signaling
cascade was still sufficient to generate large [Ca
2 ]i signals
with peak values of 300–700 nM (Fig. 7 B), which clearly
exceed threshold values for the Ca
2 -driven translocation of
PKC . HEKPKC –YFP cells were again transfected with vari-
ous amounts of a PKC –CFP-encoding cDNA plasmid.
Furthermore, the molar ratios between stably expressed
PKC –YFP and transiently expressed PKC –CFP were de-
termined at the single-cell level. The transient coexpression
of PKC –CFP concentration-dependently suppressed the
carbachol-induced plasma membrane docking of PKC –
YFP. This reduction was  70% at an  1:1 molar ratio, and
saturation of the inhibitory effect was evident at a threefold
molar excess of PKC –CFP over PKC –YFP (Fig. 7 C).
Figure 7. PKC  concentration dependently suppresses the receptor-
induced translocation of stably expressed PKC . (A) A HEK cell line 
that stably expresses low levels of PKC –YFP (HEKPKC –YFP) was 
generated and transfected with the H1 histamine receptor. Cells 
were stimulated with either histamine (100  M) or carbachol (100  M; 
acting via an endogenous muscarinic receptor) as indicated. The 
plasma membrane association of PKC –YFP was assessed before 
(open bars) and 20 s after agonist application (black bars) by confocal 
line-scan microscopy as described in Fig. 5. Data of three to six 
cells per experiment were averaged and expressed as means and 
SEM of four independent experiments. (B) Carbachol (100  M)-
induced [Ca
2 ]i signals were determined in fura-2–loaded single 
HEKPKC –YFP cells (gray lines). The mean [Ca
2 ]i is superimposed 
(black line). (C) HEKPKC –YFP cells were again transfected with 
PKC –CFP. An endogenous muscarinic receptor was stimulated 
with carbachol (CCh; 100  M), and PKC translocation was assessed 
as described in Fig. 3. The maximal translocation of PKC –YFP in 
response to the agonist was normalized to cells that did not express 
additional PKC –CFP (open bar). Molar ratios of PKC  and PKC  
expression were calculated from the fluorescence intensities of the 
differently tagged PKC fusion proteins in single cells, and cells were 
grouped as indicated. Data represent means and SEM of seven 
independent transfection and imaging experiments.Competitive DAG binding of protein kinases C | Lenz et al. 297
Although imaging experiments were instrumental in de-
fining the competitive translocation mechanism, transloca-
tion of endogenous PKCs is commonly quantified by West-
ern blot analysis of PKCs in soluble and particulate cell
fractions. The moderate appearance of PKC –YFP in the
particulate fraction of carbachol-stimulated HEK cells (Fig.
8) is not in agreement with the robust translocation seen in
imaging experiments. The distribution of classical PKCs to
soluble or particulate fractions strongly depended on the ex-
traction method. Stimulation of HEK cells with carbachol
(100   M) or ionomycin (10  M) in a Ca
2 -containing
buffer resulted in a weak redistribution to the particulate
fraction when extracts were prepared in Ca
2 -free media. In
Ca
2 -containing extraction buffers, however, the classical
PKC  was mainly found in the particulate fraction, even in
the absence of the agonist (Fig. 8). As expected, the PKC ac-
tivator PMA (10  M for 5 min) redistributed PKC –YFP
to the particulate fraction in both extraction media. Thus,
secondary redistribution during extraction precludes a deter-
mination of DAG-anchored fractions of the classical PKC
isoforms. It may, therefore, be advantageous to study the
competitive mechanism by monitoring the distribution of
the novel PKC  that docks to DAGs in a Ca
2 -indepen-
dent manner. The translocation of endogenously expressed
PKC  as a competitor can hereby be favored or suppressed
by intracellularly loaded BAPTA.
The competitive DAG binding of endogenously expressed
PKC isoenzymes was assessed in neonatal rat aortic smooth
muscle cells (AoSMCs) that express PKC , PKC 2 (trace
amounts), PKC , and PKC , as detected by immunoblot
analysis (unpublished data). Incubation with PMA almost
quantitatively translocated PKC  but only partially distrib-
uted PKC  to the particulate fraction, indicating that the
stability of the interaction between the phorbol ester and the
classical PKC is lower. After stimulation of an endogenously
expressed V1 vasopressin receptor with arginine-vasopressin
(AVP; 1  M) for 10 or 30 s, both PKC  and PKC  were
partially distributed to the particulate fraction. The selected
time points correspond to the observed maximal transloca-
tion of fluorescent PKC  and PKC  fusion proteins in tran-
siently transfected and AVP-stimulated AoSMCs (unpub-
lished data). In BAPTA-loaded cells, the stimulation with
AVP failed to translocate PKC , whereas translocation of
the PKC  isoform was more efficient in BAPTA-loaded cells
(Fig. 9). Thus, elevated [Ca
2 ]i does not only support the
agonist-induced translocation of classical PKCs, but also in-
versely affects the DAG binding of a novel PKC. This obser-
vation supports the concept that a competitive binding of
classical and novel PKCs to DAGs contributes to a selective
plasma membrane recruitment of PKC isoforms.
Discussion
Coimaging of fluorescent fusion proteins revealed that a se-
lective plasma membrane recruitment of classical and novel
PKC isoforms can result from a Ca
2 -controlled competitive
binding to the lipid second messenger DAG. Without addi-
tional [Ca
2 ]i signals, PKC  displayed a higher DAG bind-
ing affinity than PKC , resulting in a selective plasma mem-
brane translocation of the novel PKC isoform. By contrast,
in the presence of [Ca
2 ]i signals, classical PKCs bind to the
plasma membrane with a diffusion-limited kinetic. Being re-
distributed to a two-dimensional plasma membrane com-
partment, the local increase of PKC  concentration within
the target compartment is sufficient to occupy a majority of
accessible DAG molecules and thereby prevents or displaces
the DAG binding of novel PKCs. The Ca
2 -controlled
competitive translocation of classical versus novel PKC iso-
Figure 8. Extraction of PKC –YFP in the absence or presence of 
Ca
2 . HEK cells were stably transfected with YFP-fused PKC . 
After treating cells with either buffer ( ), ionomycin (iono; 10  M, 
2 min), carbachol (CCh; 100  M, 15 s) or PMA (10  M, 5 min). 
Cells were lysed in either Ca
2 -free (nominally Ca
2 -free buffer 
supplemented with 0.5 mM EGTA) or Ca
2 -containing (1 mM) 
extraction buffers as indicated. Soluble and particulate fractions 
were separated and analyzed by fluorescence spectroscopy to obtain 
the ratio of fluorescence intensities (Fparticulate/Fsoluble). Data represent 
means and SEM of four independent extraction experiments.
Figure 9. The translocation of PKC  and PKC  in vascular smooth 
muscle cells is controlled in a Ca
2 -dependent manner. Neonatal 
rat AoSMCs were pretreated with or without BAPTA-AM and 
subsequently stimulated with AVP (1  M) for the indicated times. 
Particulate and soluble fractions were probed for endogenously 
expressed PKC  and PKC  as indicated. PMA stimulation (10  M, 
5 min) was included as a control.298 The Journal of Cell Biology | Volume 159, Number 2, 2002
forms was also detectable at physiological expression levels.
This mechanism may enable a cell to decode stimuli by a di-
rected membrane translocation and activation of distinct
PKC isoforms.
Imaging of fluorescent PKC fusion proteins has provided a
more realistic impression of the dynamics of these signaling
molecules (Sakai et al., 1997; Feng and Hannun, 1998; Feng
et al., 1998; Almholt et al., 1999; Codazzi et al., 2001).
Most strikingly, the repetitive translocation of classical PKCs
during oscillatory [Ca
2 ]i responses was only detectable us-
ing these techniques (Oancea and Meyer, 1998; Dale et al.,
2001; Schaefer et al., 2001). Currently available data on sub-
type-specific translocations of PKC isoforms predominantly
rely on Western blot analyses of particulate and soluble cell
fractions. This approach, however, does not necessarily re-
flect the distribution of PKCs at a given time point. In par-
ticular, during subcellular fractionation, classical PKCs may
lose their membrane attachment (Kiley et al., 1990; Fig. 8).
A secondary loss of membrane contact of classical PKCs dur-
ing fractionation may result from (a) release of classical
PKCs that are bound solely through a Ca
2 -dependent inter-
action with phosphatidylserine and/or (b) a low affinity of
classical PKCs for DAG binding, which is not sufficient to
maintain the membrane-bound state if additional stabiliza-
tion by Ca
2  is lost. The contribution of both mechanisms
may be indirectly inferred from the capability of Ca
2 -
bound classical PKCs to prevent the DAG binding of the
novel isoforms. Indeed, when [Ca
2 ]i was clamped to resting
concentrations (50–80 nM), translocation of PKC  was im-
paired whereas PKC  appeared to access DAGs more easily.
In living cells, several lines of evidence point to a higher
DAG binding affinity of PKC  as compared with PKC .
Low concentrations of membrane-permeable DOG pref-
erentially recruited PKC  to the plasma membrane. Sec-
ond, receptor stimulation in BAPTA-loaded cells effectively
translocated PKC , but not coexpressed PKC , and, in vas-
cular smooth muscle cells, PMA treatment resulted in a
complete translocation of endogenous PKC , whereas the
redistribution of PKC  was only partial. The DAG binding
of recombinantly expressed and purified PKC isoenzymes
has been determined using phorbol esters as DAG surro-
gates. Both absolute and relative binding affinities of differ-
ent PKC isoforms, however, strongly depend on the lipid
composition and the dispersion technique to generate artifi-
cial membranes (Kazanietz et al., 1993; Dimitrijevic et al.,
1995). Therefore, reconstitution experiments do not neces-
sarily reflect the DAG binding of PKC isoforms in living
cells. Despite its inability to estimate absolute affinities, si-
multaneous imaging of PKC isoforms in living cells can be
applied to compare the DAG binding of different PKC
isoenzymes within their physiological environment. Another
advantage of imaging versus extraction experiments is the
coverage of the entire time course of a receptor-induced
PKC redistribution. Co-imaging of classical and novel PKCs
now revealed that the translocation of the classical isoforms
precedes the maximum of the membrane anchorage of novel
isoforms. For a given cell type and agonist, the observation
of selective translocations of PKC isoforms is, therefore, not
only influenced by extraction techniques but also by the
choice of the incubation time.
The Ca
2 -controlled competitive translocation of classical
and novel PKCs represents a mechanism by which signal di-
versification may emerge downstream of receptor activation.
Although stimulation of PLC-coupled receptors commonly
induces both [Ca
2 ]i and DAG signals, their relative contri-
bution to the PKC translocation underlies additional regu-
lation. The catalytic activity of phosphoinositide-specific
PLCs cleaves PIP2 to form equimolar amounts of DAGs and
InsP3. In contrast to the direct interaction of DAGs with
PKCs, InsP3 action additionally depends on the filling state
and responsiveness of internal Ca
2  stores. Refractory Ca
2 
stores have been demonstrated to result from InsP3 recep-
tor downregulation (Wojcikiewicz and Nahorski, 1991;
Bokkala and Joseph, 1997; Willars et al., 2001) or from a
cGMP-dependent phosphorylation of IRAG, an InsP3 re-
ceptor-associated cGMP kinase substrate (Schlossmann et
al., 2000). Furthermore, owing to the biphasic effect of Ca
2 
and ATP on InsP3 receptor gating, InsP3 can only operate at
certain cytosolic conditions (Mak et al., 1998, 1999).
A competition for DAG binding of classical and novel
PKCs requires that the number of accessible DAG molecules
is limiting. Our data demonstrate that the Ca
2 -induced dis-
placement of DOG-bound PKC  by PKC  is restricted to
low concentrations of the membrane-permeable DAG ana-
logue. The number of DAG molecules that are formed upon
receptor stimulation can be roughly estimated. The InsP3 re-
ceptor is fully activated in the presence of 10
 8 to 10
 7 M
InsP3 (Mak et al., 1998), which corresponds to a number of
12,000–120,000 molecules in a given cell of 2 picoliter vol-
ume. In various cell types, phorbol ester binding experi-
ments have revealed a number of 40,000–800,000 binding
sites per cell (Trilivas and Brown, 1989; Obeid et al., 1990;
Combadière et al., 1993). Although these binding sites pre-
sumably include other DAG receptors, such as PKD, chi-
maerins, Munc13-1, or Ras-GRP, the total number of DAG
acceptors, including classical and novel PKCs, appears not
to be in vast excess over the number of DAGs formed during
receptor stimulation.
From measurements of the total cellular DAG, one can
calculate that a single cell contains 5   10
5 to 10
8 DAG
molecules (Kiley et al., 1991; Baldassare et al., 1992). The
high basal values and the modest increases upon receptor
stimulation indicate that a major fraction of the total DAG
content cannot be accessible for PKCs. A more detailed
analysis has revealed that in resting cells, DAGs with satu-
rated or monounsaturated fatty acids are predominant,
whereas PLC activity mainly forms polyunsaturated DAG
species, and the hypothesis that distinct DAG species, rather
than changes in the total DAG mass, regulate PKC has been
raised (Eskildsen-Helmond et al., 1998; Ivanova et al.,
2001). A delayed formation of DAGs in the absence of
[Ca
2 ]i signals has been attributed to the catalytic activities
of phosphatidylcholine-specific PLCs or PLDs. Whether
this second wave of DAG formation leads to PKC activation
is still under debate (Pettitt et al., 1997). Furthermore,
PKC, via a noncatalytic pathway, is regarded as an activator
of PLD activity rather than a target of PLD-induced DAG
formation (Singer et al., 1996; Zhang et al., 1999). Con-
sistent with the idea that second messengers formed by
PLC activity may be scavenged by heterologously expressedCompetitive DAG binding of protein kinases C | Lenz et al. 299
proteins, a modified InsP3 receptor fragment, the “InsP3
sponge,” has only recently been introduced as a transfectable
tool that intracellularly captures InsP3 and prevents the
agonist-induced Ca
2  mobilization from internal stores
(Uchiyama et al., 2002). Kinase-dead PKC isoforms have
been considered as dominant negative modulators of endog-
enous pathways (Ohba et al., 1998; Matsumoto et al., 2001;
Braz et al., 2002). Although competition of kinase-dead and
wild-type PKC  for receptor for activated C-kinases binding
has been demonstrated (Pass et al., 2001), the dominant
negative mechanism is far from being clarified. Our data
suggest that dominant negative effects of overexpressed
PKCs may also result from scavenging the accessible DAG
molecules.
In contrast to experimental settings, physiological re-
sponses to hormones or paracrine stimuli have to decode
slight changes in agonist concentrations that cause only sub-
maximal receptor occupancy and weaker DAG formation.
Therefore, competitive processes between DAG-binding sig-
naling molecules are likely to occur in vivo. The highly effi-
cient Ca
2 -driven plasma membrane association of classical
PKCs and the superior DAG binding affinity of the novel
PKC  represent a finely tuned system where [Ca
2 ]i serves
as a switch for the subtype-selective activation of PKCs. As a
consequence, the competitive and/or sequential isotype-spe-
cific PKC activation is one of the mechanisms through
which specific physiological responses may emerge from the
signaling network of PKCs.
Materials and methods
Cell culture and transfections
HEK293 and primary cultures of rat embryonic AoSMCs (Reusch et al.,
2001) were grown in MEM (Biochrom) supplemented with 10% FCS, peni-
cillin (50 U/ml), and streptomycin (50 U/ml). Cells were seeded on 6-cm
dishes and transfected the following day at 50–70% confluency with a Fu-
gene 6 transfection reagent (Roche Molecular Biochemicals) and 4  g of
total plasmid cDNA per well according to the manufacturer’s recommen-
dations. After 18–24 h, cells were trypsinized and seeded on glass cover-
slips. All experiments were conducted 48–72 h after transfection. For se-
lection and maintenance of the stably transfected HEKPKC –YFP cell line, the
culture medium was supplemented with G418 (750  g/ml). Vascular
smooth muscle cells were starved in serum-free culture medium for 1 d be-
fore the experiments.
Generation of fluorescent PKC fusion proteins 
and fluorescence imaging
PKC ,  1, and   were COOH-terminally fused to YFP in a custom-made
pcDNA3-YFP fusion plasmid as described earlier (Schaefer et al., 2001).
CFP fusions were generated analogous to the YFP-fused PKCs but using a
custom-made pcDNA3-CFP vector that contains the open reading frame of
enhanced CFP (Invitrogen) instead of enhanced YFP. Fluorescence imag-
ing was performed with a monochromator and a cooled CCD camera
(TILL-Photonics) connected to an inverted epifluorescence microscope
(Axiovert 100; Carl Zeiss MicroImaging, Inc.). A 505-nm dichroic mirror
(inflection point) with extended reflectivity (300–500 nm) was combined
with a 510-nm long pass filter allowing coimaging of fura-2, CFP, and YFP
signals. All imaging experiments were performed in a Hepes-buffered solu-
tion (HBS) containing 128 mM NaCl, 6 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 5.5 mM glucose, 10 mM Hepes (pH 7.4), and 0.2% (wt/vol) BSA.
Excitation spectra (320–490 nm) of single fluorochromes were taken either
in untransfected HEK cells loaded with 4  M fura-2AM (Molecular Probes)
or in cells transiently expressing either CFP or YFP. Fura-2–loaded cells
were equilibrated for 3 h in HBS supplemented with 10  M ionomycin
and 10 mM Ca
2  or 10 mM EGTA instead of Ca
2  in order to record exci-
tation spectra of Ca
2 -bound fura-2 or free fura-2, respectively. Spectra
were taken for each fluorochrome, dichroic mirror, and objective used in
this study. Reference spectra were stored after subtracting background sig-
nals and normalizing the data to the maximal intensity of each dye. For
coimaging of fluorescent proteins and [Ca
2 ]i, HEK cells were loaded with
2–4  M fura-2AM for 30 min at 37 C. To obtain a measure for the mem-
brane translocation of PKC isoenzymes, regions of interest were defined
over the outer border (typical thickness of regions, 1–2  m) and over the
cytosol of a cell as shown in Fig. 3 A. Fluorescence intensities over the ex-
pected localization of the plasma membrane were averaged (Fmemb) and di-
vided by the mean fluorescence intensity over the cytosol of the same cell
(Fcyt). To detect agonist-induced changes in the plasma membrane associa-
tion, the resulting ratios were normalized to the initial values.
Confocal imaging of CFP- and YFP-fused PKCs was performed with an
LSM510 inverted laser scanning microscope and a 63x/1.4 Plan-Apochro-
mat objective (Carl Zeiss MicroImaging, Inc.). CFP was excited with the
458-nm line of an argon laser, and emitted light was collected with a 470–
500-nm band pass filter. YFP was excited with the 488-nm laser line, and
emission was recorded with a 530–560-nm band pass filter. For photolysis
of caged Ca
2 , cells were loaded with 10  M o-nitrophenyl-EGTA-AM
(Molecular Probes; 40 min at 25 C), washed, and incubated for another 30
min in HBS before the experiment. Caged Ca
2  was photolyzed in defined
areas by briefly switching the 364-nm line of an argon laser to maximal in-
tensity. Pinholes were adjusted to yield optical sections of 0.7–1.4  m.
Regression-based spectral evaluation of multiple fluorochromes
At any combination of excitation and emission wavelengths i, the back-
ground-corrected signal of the probe Fi is additively composed of fluores-
cences emitted from m different dyes fi,m: Fi    (fi,1 ... fi,m). Because fi,m
scales with both the unknown relative concentration of the dye cm and its
normalized fluorescence intensity at the chosen wavelength settings xi,m
(Fig. 1 A), the term fi,m   c mxi,m dissects known (xi,m) and unknown (cm)
parts. The signal of the probe can be described as Fi    (c1xi,1 ... cmxi,m)
(Fig. 1, B and C). The determination of fluorescence intensities of the probe
at n different combinations of excitation and/or emission wavelengths pro-
vides n independent solutions for Fi. The resulting linear systems of equa-
tions can be solved if the number of different spectral settings n equals or
exceeds the number of unknown relative dye concentrations c1..cm (pro-
vided that linear dependence between the solutions can be excluded). For
best reliability, we solved overdetermined (n   m) linear systems of equa-
tions by means of multivariate, constrained (c1..cm   0), linear regression
analyses:
As a result, the relative concentrations of free (cfura-2) and the Ca
2 -bound
fura-2 (cCa–fura-2) are known, and interfering signals of GFP variants are elimi-
nated. Therefore, the equation [Ca
2 ]i   224 nM   cCa-fura-2/cfura-2 can be ap-
plied to calibrate [Ca
2 ]i. The regression analysis was repeated for each im-
age pixel at any time point resulting in a spatially and/or temporally resolved
calibration of the [Ca
2 ]i and in a dissection of signals arising from coex-
pressed CFP- and YFP-fused proteins. Furthermore, the molar ratio between
CFP- and YFP-tagged fusion proteins can be assessed at the single-cell level.
Based on the equimolar expression of CFP and YFP in an intramolecularly
fused CFP–YFP tandem protein, a compensation for the lower fluorescence
intensity of CFP could be calibrated. In our optical system used for coimag-
ing of [Ca
2 ]i, CFP, and YFP, the fluorescence of YFP (cYFP) appeared 8.1-
fold brighter than for the intramolecularly coupled CFP (cCFP; as detected af-
ter complete disruption of fluorescence resonance energy transfer by YFP
photobleaching). Thus, the term cYFP:8.1   cCFP corresponds to the molar ra-
tio between coexpressed YFP- and CFP-fused proteins.
Cell fractionation and immunoblotting
For detection of PKCs in cytosolic and particulate fractions, cells were ho-
mogenized by two 5-s pulses of sonification (Branson sonifier) in an ice-
cold lysis buffer containing 25 mM Tris/HCl, pH 7.5, 2 mM EDTA, 0.5 mM
EGTA, 1 mM DTT, 200  M phenylmethylsulfonyl fluoride and leupeptin/
aprotinin (20  g/ml each). Particulate material was removed (30,000 g, 20
min at 4 C), and supernatants representing the soluble PKC fractions were
collected. The pellets were resuspended in lysis buffer supplemented with
c1
c2
c3
.
.
cm
Σxi1xi1 Σxi1xi2 Σxi1xi3 ..Σxi1xim
Σxi2xi1 Σxi2xi2 Σxi2xi3 ..Σxi2xim
Σxi3xi1 Σxi3xi2 Σxi3xi3 ..Σxi3xim
... . . .
... . . .
Σximxi1 Σximxi2 Σximxi3 ..Σximxim
1 –
Σxi1Fi
Σxi2Fi
Σxi3Fi
.
.
ΣximFi
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1% (wt/vol) Triton X-100, sonified (5 s), and placed on a rocking platform
(20 min at 4 C). Supernatants of a second centrifugation (30,000 g, 20 min
at 4 C) were assigned as particulate PKC fraction. For immunoblotting,
samples were diluted in Laemmli buffer containing 10%  -mercaptoetha-
nol and subjected to a 10% SDS-PAGE. Separated proteins were electro-
blotted on nitrocellulose membranes, blocked in PBS containing 5% non-
fat dry milk, and probed with polyclonal rabbit anti-PKC  or anti-PKC 
antisera (1:1,000 in PBS; BD Biosciences) and a secondary, peroxidase-
coupled anti–rabbit IgG antibody (Sigma-Aldrich). Chemiluminescence
was detected with a Lumiglo reagent (New England Biolabs, Inc.).
The expression levels of endogenously expressed PKC isoenzymes and
of heterologously expressed PKC fusion proteins were assessed in cytosolic
fractions prepared from quiescent cells. 20  g of protein or diluted sam-
ples of the transiently overexpressing cells were loaded on the gel. The
transfection efficiency in these experiments was  50%, as detected by
counting the total number and number of fluorescent cells.
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